Schedule 13D ownership disclosure

Aytu BioPharma Inc

Security class unavailable · CUSIP: 054754858

Event date: 2023-06-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
19.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-072336
Form type
SC 13D/A
Filer
AYTU BIOPHARMA, INC
CIK
CIK 1385818
Filed
Jun 16, 2023
Reporting period
Jun 13, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub